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1. Introduction 
This paper provides a critical  review of the literature on innovative clusters in biotechnology. It 
examines the main contributions on this subject, trying to identify some robust stylised facts, the main 
puzzles and unresolved questions concerning the ingredients and the dynamics of the geography of 
innovation in this industry. 
Clusters of production and innovation have become in the last two decades a major focus of 
attention for social scientists and policy makers. Theoretically, the observation that production and 
innovative activities tend in many cases to concentrate in specific geographic areas obviously raises the 
questions about the relevance of space in shaping economic activities  and about the nature of the 
mechanisms and processes that lead to agglomeration. 
Clusters have become also important in terms of policy-making, as they have been increasingly 
considered as drivers of economic growth and innovation, on the basis of the assumption that there are 
advantages to economic agents located in a cluster and that innovation is more likely to occur in 
clusters. The Silicon Valley at one extreme, Italian industrial districts on the other have become a sort 
of “influential methaphysics” guiding academic analysis and policy making (see e.g. Special Issues of 
Regional Studies (33/4; 1999) and World Development (27/9; 1999). Cluster policies have been 
adopted in both advanced and developing countries and, in some cases, these have been considered 
drivers of national economic growth (UNCTAD, 1998; Porter, 1998; OECD, 1999; 2001). 
The notion of clusters has spawned an enormous literature, wich includes a variety of 
approaches and methodologies, ranging from case-studies, comparative case studies, econometric 
analyses and theoretical models- having either a formalised or appreciative structure. The literature on 
clusters traces its origins in trade theory, regional economics and economic geography, but it has been  
increasingly overlapping with other streams of literature, including innovation studies, industrial 
dynamics,  small firms, entrepreneurship,  networks, etc... 
While these contributions have significantly improved our knowledge of the factors that lead to the 
clustering, several fundamental issues remain controversial and poorly understood. Among them: 
- the relative role of alternative mechanisms that have been proposed as possible explanations of 
the observed concentration of productive and innovative activities, in particular as it concerns 
the nature of what are now commonly defined “local knowledge spillovers” (LKS); 
- even more important, the nature of the dynamic processes – as distinct from or overlapping with 
the “ingredients” – that might produce clustering. 
Rather than addressing the whole literature on clusters, this paper takes a much more narrow focus. 
It concentrates on the relationships between clusters and innovation; and looks at one particular 
industry (or technology), i.e. biotechnology. 
Biotechnology is a particularly challenging case within this stream of literature, for a variety of 
reasons, but mainly because it is an extreme case which provides more puzzles than answers. 
First of all, biotechnology is a highly innovation – intensive industry where spatial agglomeration 
appears indeed to be quite a prominent characteristic of its development. Yet, it has become 
increasingly questioned how precisely space influences innovation in this field and what are the 
specific mechanisms leading to agglomeration, even coming to the conclusion in some cases that the 
role of geography might have been vastly exaggerated. So, this case provides an intriguing opportunity 
for discussing the mechanisms and processes that generate geographical concentration of innovative 
activities. 
Rather than trying to provide definite answers, the main aim of this this paper consists in flagging 
out puzzles and unresolved problems. In particular: 
i) to what extent is clustering a necessary feature of innovative processes in this industry? 
ii) in what way is space really important in determining innovation in biotechnology? 
iii) Can one identify specific ingredients and specific processes that lead to emergence and 
development of clusters? Can on meaningfully distinguish between “ingredients” and 
“processes”? 
iv) What are the factors that might explain the genesis of clusters and what are the factors that 
sustain clusters once they have emerged? Do they coincide or are they different? 
v) Among the processes that create innovative clusters, what is the role of various forms of 
agglomeration factors? 
vi) What are, if any, the specific properties of the technology and of the related innovative 
activities that favour processes of clusterisation in the biotech industry and sustain specific 
agglomeration forces? 
vii) More generally, are clusters producing innovation or is it innovation that creates clusters? 
 
Against this background, an excessively provocative, but perhaps useful, way of framing the 
paper  is to take the devil’s advocate position and putting forward the “null hypotheses”: 
i) innovative activities in biotechnology are less concentrated than it meets the eye; 
ii) space as such is not a fundamentally important determinant of innovation in this 
technology / industry 
iii) what matters in triggering agglomeration processes are networks of relations which have 
only partially a clear spatial dimension; 
iv) in particular, localised knowledge spillovers are not important drivers of agglomeration; 
rather, concentration of innovative activities is linked primarily to pre-exisiting and self-
reproducing bodies of previously accumulated knowledge, thick labour markets for 
highly skilled labour and  - in general – to more formal and formalised mechanisms of 
transmission of knowledge, many of which are not specifically spatially constrained. 
After the review of the literature, I’ll come to a much more nuanced position that acknowledges: 
a) the relevance of the spatial dimension, but mainly as a reflection of the spatial concentration 
of cutting edge research in selected universities and public research organisations, and 
mainly at the level of research groups ; 
b) the relevance of localised processes of creation and transmission of knowlege, which are 
however only partialy linked to knowledge spillovers and have more to do with active 
processes of construction of supporting institutions; 
c) the importance of markets for technology and of attempts at privately appropriate the 
economic benefits stemming from academic research but also of other less formal 
mechanisms for the creation, diffusion and economic exploitation of knowledge. 
The paper is organised as follows. Section 2 provides a broad, but brief, overview of some key 
issues in the literature of clusters that set the stage for the subsequent discussion of the case of 
biotechnology ( Section 3). In particular,  paragrah 3.1 proceeds to review briefly the evidence 
about agglomeration in biotechnology; paragraph 3.2 examines the ingredients of biotechnology 
clusters; paragraph 3.3 discusses what is known about the processes of spatial agglomeration in 
biotech, especially as it concerns local knowledge spillovers and other mechanisms based on 
increasing returns. Section 4 concludes the paper. 
 
2. Clusters of innovative activities: some basic questions and open problems  
2.1  The Spatial Embeddness of  Innovation 
The observation that economic activities are spatially embedded has a long history in economic 
analysis, that goes back at least to to Von Thunen and Marshall and constitutes the starting point of 
sub-disciplines like regional economics, economic geography, trade. In more recent years, a variety of 
intertwining factors have focused attention on the more specific phenomenon of clusters of innovation, 
as distinct from clusters of production activities. 
A first reason is the increasing recognition of the role of innovation (and more generally of 
learning) as an engine of economic growth, at various levels of spatial disaggregation. Thus, “regional 
economists”and  “economic geographers “ – as well as policy makers - have started to thoroughly 
consider how innovation can be generated and sustained in specific geographic areas and regions. 
On the other hand,  it has been observed that innovative activities are often geographically 
concentrated. As such, this observation might not necessarily be a shattering new discovery.  After all, 
it has been  a well known fact to historians and economists studying technological change that not only 
innovation has been historically strongly concentrated in few countries; but also that the club of 
innovators has remained quite small with few notable exceptions (often linked to major technological 
revolutions); and that countries tend to exhibit stable patterns of technological specialisation (Dosi et 
al., 1994; Cantwell, 1989).  These observations are indeed a fundamental building block of the various 
forms of the “national systems of innovation” approaches (Nelson, 1991; Edquist 1997), whereby these 
phenomena are essentially explained on the basis  of some key characteristics of technical knolwedge, 
like its tacit and cumulative nature, coupled with the recognition of the systemic nature of innvative 
activities, which involve diverse interactions between different agents, competencies, institutions. 
However, three further findings have sparked new research in the field of the geography of 
innovation. First, it has been observed that innovation is more spatially concentrated than production 
activities (Audretsch and Feldman, 1996). Second, concentration of innovative activities occurs at 
spatial dimensions much smaller than nation states, i. e. regions, areas, cities, etc.. Third, firms located 
in innovative clusters tend to be systematically more innovative than firms located elsewhere. Jointly, 
these observations have led to the notion that innovative processes are intimatley embedded is space 
and and have opened a set of questions concerning the specific characteristics of particular areas that 
make them conducive to innovation. 
A review of this enormous body of literature goes far beyond the scope of this paper. Suffice it 
to say here – in a heroic simplification – that  research into the spatial dimension of innovative 
activities has basically reformulated in a new setting the main questions that have been addressed  for 
more than a century by social scientists interested in the spatial dimension of economic activities. 
Quoting Bottazzi et al, 2002: 
(i) Why and when can  one observe persistent spatial 
patterns that cannot be explained by resorting to pre-existing 
heterogeneity in agents and locations (i.e. by some kind of 
“comparative advantage theory” alone) ? 
(ii) What are the agglomeration  and dispersion 
forces that generate spatial concentration (and possibly its 
destabilization) ? 
(iii) What is the role of mere “chance” in the observed 
spatial concentration of economic activities ? 
(iv) How and when emerging spatial structures of 
production and innovation tend to become self-sustained 
over time ? (And, conversely, what make them wither away 
?) 
 
2.2 Endownments, agglomeration forces and localised knowledge spillovers 
It is fair to say that, despite the staggering amount of empirical work that has been produced, the 
answers to all these questions remain highly controversial. 
As it concerns point (i) and (ii), there seems to be a wide consensus that clustering in innovative 
activities cannot be simply explained by some sort of given and immobile “endownments”, but that 
powerful agglomeration forces must be at work in order to produce geographical concentration. 
However, what  these forces are precisely and what is their relative explanatory role remains unclear. 
And, in some cases, the doubt can legitimately arise that perhaps some of these agglomeration 
mechanisms could be interpreted more simply as  “endownments” or viceversa, as it will be argued at 
more length later on.  
In fact, the development of the geography of innovation have concentrated their explanations to 
these questions essentially on various reformulations of the fundamental sources of agglomeration 
externalities originally suggested by Marshall (see Henderson (1986) and Krugman (1991) among 
others): 
a) Economies of intra-industry specialisation: a localised industry can support a greater number 
of specialised local suppliers of industry-specific intermediate inputs and services, thus 
obtaining a greater variety at a lower cost. 
b) Labour market economies: a localised industry attracts and creates a pool of workers with 
similar skills, which benefits both the workers and their employers. 
c) Ease of communication among firms: information about new technologies, goods and 
processes seem to flow more easily among agents located within the same area, thanks to 
social bonds that foster reciprocal trust and frequent face-to-face contacts. Therefore 
adoption, diffusion and innovation seem faster and more intense in geographical clusters than 
in scattered locations. That is, some ‘knowledge spillovers’ exist, which are geographically 
bounded. 
A significant fraction of the  theoretical literature on clusters explains   different spatial 
agglomeration patterns (from concentration of economic activities in few locations to hierarchical 
structures) as the solution of static trade-offs between  agglomeration and dispersion forces, particularly 
combinations of static externalities, transport costs and economies of scale (Papageorgiou and Smith 
(1983) and Fujita (1988, 1989, Henderson (1974). The “New Economic Geography” (Krugman (1998, 
(1991a, 1991b, 1991c, 1993), Krugman and Venables (1995, 1995a, 1996), Venables (1996), Ottaviano 
and Thisse (1998), Fujita, Krugman and Venables (1999), Puga and Venables (1996), Ottaviano and 
Puga (1998), Fujita and Thisse (1996) focuses instead on various forms of increasing returns to scale 
(or indivisibilities) at the level of individual agents as the main mechanisms leading to agglomeration 
and to ist persistence..  
However, and perhaps not too surprisingly given that innovation is the subject of the analysis of 
this stream of research, the role of knowledge spillovers has attracted the attention of scholars. The 
localised nature of such spillovers is usually associated to the tacit nature of knowledge. Thus, 
communication occurs more easily through face-to-face contacts and interactions. 
Different types of methodologies (estimation of knowledge production functions as in Jaffee 
(1989), Acs et al (1992 and 1994), Audretsch and Feldman (1996), Feldman and Audretsch (1999), 
Feldman and Florida (1994); use of patent citations to track direct knowledge flows from academic 
research into corporate R&D (Jaffee et al (1993), Almeida and Kogut (1997)); and an immense set of 
empirical case studies and narratives confirm that indeed important localisation effects exist in 
innovative activities. 
The notion of knowledge spillovers has taken a central role not only in scientific analysis but also 
in policy-making, where the a key emphasis has been attributed to the idea that interventions should be 
directed primarily towards the attempt at facilititating such knowledge flows and spillovers, through, 
e.g., offices for technology transfer, all kind of measures for strengthening university-industry 
relations, etc.. 
However, it has become increasingly acknowledged that the evidence supporting the role of 
knowledge spillovers is largery indirect and that it is quite difficult to clearly separate knowledge 
spillovers for other types of pecuniary extenalities and more generally between Marshallian 
externalities and more classic urbanisation externalities or even natural endownments (Glaeser et al., 
1992, Ellison and Glaeser (1999),  Henderson (1999)). 
In particular, as forcefully argued by Breschi and Lissoni (2001), it is has proven hard to precisely  
show how knowledge spillovers actually work and even whether they can legitimately interpreted as 
spillovers. To begin with, in econometric studies spillovers are often identified as a sort of a residual, 
rather than directly. But that residual might actually include many different processes that do not 
necessarily coincide with knowledge spillovers. Thus, for instance, in diverse instances, the pool of of 
knowledge that should constitute the very origin of knowledge spillovers seems to be embodied in 
specific people and/or in a pool of specialised workforce, as argued for example by Zucker et  al. 
(1998, 1998a) and Almeida and Kogut (1999). 
Similarly, knowledge within a clusters in many cases does not appear to  simply “spill over”. 
Rather, access to such knowledge seems to require deep involvement in the research process and 
bench-level scientific collaboration and the conscious investment of resources not simply to search for 
new knowledge, but to build the competencies to absorb the knowledge developed by others. Finally, in 
other cases, knowledge flows occur via (localised) mobility of researchers and of the workforce and are 
mediated by market transactions or other institutionalised or quasi-institutionalised mechanisms 
involving not simply mutual trust and face-to face contacts, but highly complex economic and social 
structures. 
Thus, in a highly influential paper, Lamoreaux and Sokoloff (1997) have criticised the assumption 
that inventors and firms operating in a specific industry and in close spatial proximity to each other will 
be more innovative than those who are geographically isolated because of the greater likelihood that 
they will share (tacit) knowledge. Using historical patent data for the US, the authors tracked the career 
patterns of a number of inventors, in order to relate the production of inventions to regional 
manufacturing activities. Summarising, their results suggest that concentration of firms and production 
in a given area was not per se a necessary, let alone sufficient condition to determine high rates of 
innovative activity. To put in slightly different terms, static externalities related to the current scale or 
size of an industry in a given area did not necessarily generate better (local) information flows to the 
advantage of innovative activities. What seemed to matter more was the accumulated stock of 
knowledge (dynamic externalities) in a diversity of industries as well as the levels and types of human 
capital in a region.  
These results may well reflect radically different patterns of organisation of industrial and 
innovative activities as compared to the ones prevailing now. However,  other studies (e.g. Lyons 1995, 
Echeverri-Carroll and Brennan 1999 among others. See also Giuliani, 2004, for further results and a 
broader discussion of these issues) suggest that local sources of knowledge are key in determining 
success in the development of new products and processes only in areas with a large accumulation of 
knowledge (e.g. Silicon Valley). On the contrary, innovations in firms located in cities with a relatively 
small accumulation of knowledge depend on the relationships with universities and other high 
technology firms (suppliers and customers) located elsewhere, especially in higher-order urban centres. 
The most dynamic and innovative firms look for knowledge embodied in engineers and scientists 
wherever they are available, and are not necessarily constrained in this by geographical barriers. Local 
knowledge sources are relatively less important for firms located in lower-order regions. For these 
firms, local universities are viewed as suppliers of skilled workforce, rather than loci of innovations or 
sources of product ideas or spillover effects. In order to sustain high rates of innovation they must 
develop linkages with actors (universities and other high-tech firms) located in higher-order regions. 
2.3 Clusters and networks 
The issue becomes even more tangled whenever the cluster is directly assimilated to the concept of  
networks. Indeed, almost all the available analyses of clusters rely – directly or metaphorically – on the 
idea that  the agglomeration forces that keep innovative activities localised are expressions of networks 
of (localised) relationships among agents, be they different types of firms, venture capitalists, academic 
scientists, local institutions, policy makers, etc.. 
However, the meaning attributed to the concept of networks varies drastically. In some cases, for 
example, networks are considered as a specific new form of organisation of innovative activities, which 
is substituting the traditional model based on internal R&D (Powell, 1996). According to this kind of 
interpretations, innovative activites tend to cluster because such kind of networks exist: the cluster is 
the outcome of the existence and development of local networks, rather than networks emerging as a 
result of specific localisation factors. 
Partly overlapping with these views, in other cases, the notion of networks is strictly associated to 
the notion of collaboration. According to this perspectives, cooperation in innovative activities and 
interactive learning are the distinct property that defines and identifies (successful) clusters (see for 
instance Cooke, 2002; Maskell, 2001). A network-like structure is a typical properties of clusters and 
networks should e viewed as the proper unit of analysis to investigate innovation: knowledge resides in 
the network and not simply in each of its constituent nodes. Within innovative clusters, firms learn 
through a variety of types of interactions, ranging from user-producer relationships, formal and 
informal collaborations, interfirm mobility of skilled workers and the spin-off of new firms from 
existing firms, universities and public research centres. Embeddeness of local firms in a thick network 
of knowledge sharing, supported by close social interactions and by (formal and informal) institutions 
that promote the development of trust among participants in the network. 
However, the concepts of networks and clusters do not coincide. More important – and quite 
obviously - networks do not necessarily imply cooperation, trust and distributed knowledge. As such, 
networks are just a language (in this sense, having the same methodological status of game theory) to 
represent and analyse interactions among agents. And in its most developed form – social network 
analysis – this approach is firmly grounded in sociology, its main object of analysis being social 
relations. Thus, there are many different types of networks and many different principles that determine 
their structure and their evolution. 
Thus, formal applications of network analysis to the study of innovative clusters as well as an 
exploding number of case studies have highlighted the extreme diversity in their structure, logic and 
dynamics. In some cases, highly hierarchical structures are observed (see for instance Orsenigo et al., 
2001). More generally, these studies had the great merit to show that (different) clusters are 
characterised by (different) highly structured patterns of knowledge diffusion and generation, produced 
by the interaction of a host of  overlapping social and economic relations. This observation further 
weakens any simplistic description of the advantages of co-localisation as the result of some kind of 
local externalities. If anything, the ability to tap into the local knowledge base and to exploit the other 
possible agglomeration externalities appears not to be unrestricted, but structured and mediated through 
specific social, organisational and economic mechanisms.Hence, clusters might emerge as the outcome 
– or as a specific sub-network – of sets of relations which are not necessarily based on spatial 
proximity, but on other forms or contiguity, like organisational proximity (Rallet and Torre, 1999), 
epistemic communities, communities of practice, etc.. Conversely, clusters might well result as the 
effect of the intersection and coalescence of different networks. 
One particularly important result of this stream of literature is that (successful) clusters are 
much more open and outward-oriented than the conventional interpretations would suggest. Rather 
than simply leveraging the knowledge available within a cluster, the existence of weak and strong ties 
with agents located outside the cluster itself increasingly appears to be a crucial feature of the more 
innovative clusters (see Bresnahan, Gambardella and Saxenian (2001) for a discussion), As such, this 
finding does not imply by any means that local sources of knowledge are unimportant. On the contrary, 
it might be interpreted as confirming that the ability to tap external sources of knowledge - absorptive 
capacities (Cohen and Levinthal (1990) -  is itself a function of the local technological capabilities.  
However, in more general terms,  this observation links with the broader question concerning 
the existence an “ideal” knowledge network structure, which can be associated with high innovative 
performances. In some respects, the debate about the advantages of Silicon Valley vs. Route 128 might 
be considered as a particular version of this direction of research.In this respect increasing attention has 
been devoted to the studies of dense networks  (Coleman 1988), to the importance of structural-holes 
(Burt, 1992) and to “small world” type of networks (Milgram, 1967; Watts, Strogatz, 1998). As 
discussed in Ahuja (2000) and Giuliani (2004), most likely an “optimal” network structure for 
innovation does not exist but, rather, different structures are likely to show different types of 
advantages and disadvantages. For example, dense networks tend to favour the formation of trust, 
which in turn limits opportunistic behaviour (Coleman, 1988) and encourage cooperation and diffusion 
of more high quality, fine-grained knowledge (Uzzi, 1997). Networks characterised by structural holes, 
instead, allow firms to expand the diversity of knowledge they can have access to (Ahuja, 2000) and 
reduce the probability of negative lock-ins (cf. Gargiulo, Benassi, 2000). Similarly, “small worlds” are 
considered a more efficient network structure as compared to a randomly interconnected one, to the 
extent that  fewer but more distant linkages increase the probability of  accessing diverse knowledge 
and allow efficiency gains in the processes of knowledge diffusion (Cowan, Jonard, 2004). 
 
2.4  Forms of the organisation of the cluster and the nature of technology 
 
In some respects, the debate about the advantages of Silicon Valley vs. Route 128 might be 
considered as a particular version of this discussion on the relative efficiency of different specific 
cluster or network structures. Annalee Saxenian (Saxenian, 1994) proposed the extremely influential 
argument that the superior performance of Silicon Valley was related to the particular form of 
organisation of innovative activities that had been developing over time, based indeed on network-like 
structures of interactions among entrepreneurial agents. On the contrary, Route 128 fared worse as a 
consequence of the dominance of a more traditional organisational structure, based on large vertically 
interated  firms.  
Kenney and Von Burg (2001) object to this interpretation that the main difference resided not so 
much in the organisational structure of the cluster as such, but in the nature of the relevant technology 
or set of technologies and related products that drive the cluster. 
Without discussing the details of this debate, it is indeed important to notice that relatively little 
attention has been paid to the relationships between the structure and performance of a cluster and the 
nature of the knowledge base and of the market opportunities upon which the cluster is based. Yet, the 
properties of the relevant technology or technologies are likely to have an important role in shaping not 
only the critical resources or endownments that might determine the success or failure of clusters, but 
also the relative importance of alternative mechanisms of agglomeration and – of course – the relative 
efficiency of alternative network structures. 
In fact,  the debate on knowledge spillovers has concentrated on one particular property of 
knowledge, i.e. tacitness. However, while the crucial importance of tacitness can be hardly 
overemphasised, knowledge and technologies are characterised also by other dimensions that have a 
profound impact on the ways through which innovation takes place (Malerba and Orsenigo, 2000). As 
argued by Malerba and Orsenigo (1997) and Breschi, Malerba and Orsenigo (2000), the nature of 
technological regimes bears a close relationship with the patterns of innovative activities.  
Thus, for example, the nature of technological opportunities and of the space in which search 
for new products and processes occurs implies specific incentives and possibilities for the entry of new 
innovators and more generally for the speed of technological change and for the organisation of 
innovative activities. High opportunities in technologies which offer ample possibilities of invention 
along  diverse trajectories and over a wide range of products, processes and market segments are likely 
to associated not only to high rates of innovation, but also by a large and fastly changing population of 
innovators, who explore different avenues and open new market niches. Similarly, technologies which 
involve the access to and the mastery of differentiated fragments of knowledge open up possibilities for 
vertical and horizontal specialisation and the development of adequate  organisational devices for the 
integration of the relevant knowledge. To some extent, the discussion about the role of specialisation 
vs. diversity, i.e. Marshallian vs. Jacobian externalities, might be interpreted also along these lines. 
Thus, Feldman and Audretsch (1999), for instance, support the view that diversity matters more than 
specialisation, finding that the number of innovations in sector i in state s owes more to tho the 
presence in the state of other industries whose science base is related to to that of industry i rather than 
to the specialisation in sector i. Henderson (1999)  however comes to different conclusions. In a similar 
vein, Bresnahan, Gambardella and Saxenian (2001) suggest that clusters tend to form taking advantage 
of new technological and market opportunities that have not already been exploited. 
The degree of cumulativeness and the appropriability conditions of technological advances are 
also likely to influence the structure of the cluster and the processes leading to (diverse structures of ) 
the cluster. Strong cumulativeness and a tight appropriability regime make the circulation of knowledge 
more difficult and tend to strengthen and reproduce over time the advantages of early innovators. This 
might lead to stronger and persistent concentration of innovative activities in few firms, to more 
hierarchical network structures and – under some further conditions – to higher degrees and persistence 
of spatial concentration (Malerba and Orsenigo (1997), Breschi and Malerba (2001). 
The combination of these and other properties of knowledge can therefore give rise to a large 
variety of different processes and structures of clusterisation (For some preliminary discussions and 
empirical evidence, see Bottazzi, Dosi and Fagiolo (2002)). In turn, alternative characteristics of the 
clusters – in terms of their endownments, patterns of internal interactions, mechanisms of 
agglomeration – may display different degrees of “fitness” with the relevant technological regime. At a 
higher level of aggregation – essentially the nation state  - these relations have started to be explored, 
among others, by Hall and Soskice (2001), Casper and Kettler (2001) in the context of the literature on 
“national frameworks for innovation”. The contributions by P. Cooke (Cooke (2002)) on “regional 
innovation systems” partly share this orientation too. More systematic attempts to map and taxonomise 
the properties of technologies and the structures of clusters might turn out to be a very promising 
avenue for future research. 
 
2.5 From static externalities to dynamic increasing returns: the genesis and evolution of 
clusters and the direction of causality between clusters and innovation 
 
In a recent paper examining the reasons why Detroit emerged as the capital city of the 
automobile industry and maintained its leadership over time, Steven Klepper (Klepper, 2002) proposes 
and tests empirically the hypothesis that this process was the outcome of a combination of chance (the 
presence in Detroit of a few key individuals, who were not, however, closely related to each other) and 
processes of spinoffs of new firms by incumbent companies. On the basis of the key assumption that 
the “best” firms generate a larger number and more efficient of spin-offs, the model produces patterns 
of agglomeration without relying on any standard notions of externalities.  
Irrespective of the merits or demerits of the specific argument and unduly generalising, 
Klepper’s approach is important because it highlights several crucial issues in the literature on clusters 
and innovation. 
First, Klepper’s argument does not rely on the standard notions of externalities, but introduces 
the idea that other forms of dynamic increasing returns might lead to clusterisation, in particular as it 
concerns the cumulativeness of innovative processes. Cumulativeness plays indeed a fundamental role 
in the explanation of the processes of concentration at the industry level (Dosi et al., (1995); Malerba et 
al (1999); Sutton, 1999) and constitutes a plausible further candidate explanatory variable for 
concentration at the spatial level. As long as innovation is cumulative, early innovators have a higher 
probability to continue to innovate in the future, at least until the emergence of new technological 
paradigms make the relevant knowledge and competencies obsolete. Shifting this argument from 
individual firms to clusters requires some additional assumptions about the mechanisms through which 
knowledge and competencies are  replicated outside the boundaries of the original innovator(s). Spin-
off processes from incumbent firms (or other organisations like universities) are certainly a plausible –
but certainly not the only  - mechanism, which does not necessarily rely on externalities. Several 
accounts of the rise of the Silicon Valley (Kenney and Von Burg, 2001 among others) emphasise, in a 
strikingly similar way, the role played by Fairchild and the Fairchildren. Furthermore, this type of 
argument suggests a further important and in principle testable implication concerning the relative role 
of new firms originated from within the clusters as compared to new firms (entrepreneurs) attracted to 
the cluster from outside, i.e. the relative importance of internal cumulativeness vs. attractiveness of the 
cluster itself. 
Second, this approach somehow raises the question about the direction of causation between 
innovation and clusters. Whereas most of the literature discussed so far focuses on the conditions that 
make a particular area conducive to innovation, - i.e. on the idea that clusters promote innovation – the 
opposite nexus of causation might turn out to be at least equally important: it is an original innovation 
that creates clusters. Quite obviously, it remains necessary to specify the mechanisms that tend to keep 
subsequent innovations within the clusters rather than spreading outside. In this respect, the degree of 
overlapping between these two extreme approaches is very high and it might be difficult to 
meaningfully separate them.  
Third, Klepper’s argument suggest that perhaps more emphasis should be attributed to specific 
characterists of the firms and of  the other key agents active within a cluster. 
As Giuliani, (2004) argues, both cluster and network studies tend to consider the meso-level 
(i.e. a cluster or a network of firms) as the unit of analysis. And hence most of research has been 
undertaken to analyze the effects of meso-level characteristics (e.g. degree of inter-firm co-operation, 
presence of localized knowledge spillovers, structural features of the networks, etc.) on the 
innovativeness and performance of the cluster or network. Less research has instead been directed to 
the understanding of how the meso-level characteristics come into being or evolve as a results of 
micro-level, non-structural characteristics. In the domain of cluster studies, for example, only relatively 
few contributions have emphasised the relationships between firms characteristics and the innovative 
outputs of clusters or regionally bounded areas (see, Harrison et al., 1996; Beaudry and Breschi 2003). 
As suggested by Caniels and Romijn (2003),  
“the regional agglomeration studies emphasize the favorable impact of 
geographical proximity on regional economic performance; but the firms that 
constitute those agglomerations largely remain black boxes. In contrast studies 
dealing with technological learning explain economic performance at firm level 
without systematically taking accounts of the effects of geographical 
proximity” (Caniels, Romijn, 2003: 1253).  
Similarly, in network studies, recent contributions have stressed that: “the bulk of network 
research has been concerned with the consequences of networks” (Borgatti, Foster, 2003: 1000) and 
that “…limited attention has been paid thus so far to how important nonstructural features – such as the 
characteristics of the organizations that represent nodes in a network, geographic location, or the 
institutional underpinnings of the larger structure – alter the character of information flows.” (Owen-
Smith, Powell, 2004: 5). 
Finally, emphasis on the “reverse causation” has the merit to recast the issue in an explicit 
dynamic way and therefore to reframe the initial question about “endownments” and agglomeration 
forces in quite a different perspective: clusters may well emerge as a sheer outcome of chance (e.g. an 
innovation) and develop through the working of (a variety of ) self-reinforcing processes, irrespective 
of any initially favourable endownment.  
As Bresnahan, Gambardella and Saxenian (2001) put it, the literature on clusters is much better 
able to provide hypotheses about how a cluster keeps going than explaining the nature of the spark that 
generate the cluster itself. Focusing on the interplay between chance, initial conditions and subsequent 
self-reinforcing  processes might help in posing the problem sharply and in understanding the subtleties 
involved in these distinctions.   
Indeed, one does not necessarily rely on chance alone in order to explain the genesis and the 
development of clusters. In many cases, particular sets of initial conditions make the onset of clusters 
more likely. For example, Bresnahan, Gambardella and Saxenian (2001) suggest that emerging clusters 
tend to share some common features: existence of unexploited technological and market opportunities, 
highly educated skilled labour, firm- and market building capabilities by pioneering firms, connection 
to markets; and luck. Another recurrent factor is the availability and concentration of state-of the art 
knowledge in key agents.  
Interestingly, variables like the presence of supporting institutions (e.g. venture capital) 
diffusion of particular social attitudes (e.g. entrepreneurship) appear to play a much lesser role in 
nascent clusters and if anyting they tend to develop later on as a product of the agents’ activities.  Thus, 
in a dynamic perspective, considering these initial conditions as “endownments” may be deeply 
misleading, insofar as they are not given, but they are themselves the result of previous processes of 
construction of competencies and institutions.  
This interpretation resonates with all those – mainly appreciative - accounts which highlight 
how the development of clusters involved complex processes of construction of competencies, 
supporting institutions, organisational structures unfolding in time by heterogeneous agents who cannot 
perfectly understand the environment in which they act (Kenney and Von Burg (2001), Feldman, 
Bresnahan et al. (2001), among others). And a now significant stream of  theoretical  literature, 
building on the seminal work by Brian W. Arthur and Paul David, has been indeed attempting to 
analyze the nature of economies/diseconomies of agglomeration in a truly dynamic framework in 
which persistent spatio-temporal patterns are conceived as emerging out of direct interactions among  
boundedly-rational, heterogeneous economic agents (cf. Arthur, 1994; Ch. 4 and 6; David et al., 1998; 
Cowan and Cowan, 1998). In explicitly dynamic settings, it becomes possible to appreciate: 
 “the complex  trade-offs become more clear between purely random 
factors and more systematic, historical forces (or, put it differently, the issue of 
necessity vs. chance) underlying the emergence of spatially ordered structures”. 
(Bottazzi et al., 2001, 9). 
 
2. 6 Some preliminary conclusions 
The debate on the nature of the externalities that generate and sustain clusters provides – as it 
often happens in economics – perhaps too many possible hypotheses for explaining the phenomenon 
under considerations, and it is intrinsically difficult to satisfactorily discriminate among them. To some 
extent, this should come as not too big a surprise, when one considers the high degree of heterogeneity 
in the structure of clusters and in the nature of the relevant technologies. Thus, it is perfectly plausible 
that different “endownments” and agglomeration forces may generate clusterisation under different 
circumstances. Clearly, this is not a particularly illuminating insight, to the extent that it dangerously 
borders the notion that “everything can happen”.  
In a slightly different perspective, the concept of clusters bears a worrying resemblance with 
other “stylised facts” which are found in industrial dynamics, like e.g. the persistence of skewed 
distribution of firms sizes. The “facts” are often what statisticians call “unconditional objects” (Brock, 
1999), i.e. they can be generated by an enormous variety of alternative processes, so that empirical 
testing becomes exceedingly difficult. Under these circumstances, it becomes necessary to impose 
much stronger restrictions on both the type of phenomena that are to be explained and on the 
alternative theories.  Thus, a theory should be able to account at the same time for a larger set of 
phenomena at the same time and these phenomena should be specified in much closer detail. 
A final point deserves mention. The literature on clusters has certainly provided strong evidence 
that innovation often tends to be spatially localised and an extremely rich variety of explanations for 
this phenomenon. Yet, less attention appears to have been attributed to the exploration of the “null 
hypotheses”:  
- Are clusters a necessary characteristic of inovation processes? 
- Are clusters unequivocally beneficial to innovation? 
 
3. The case of biotechnology 
As mentioned in in the introduction, the case of biotechnology is particularly interesting for a series 
of reasons. 
 First, it has been frequently noted that biotechnology is a strongly science-based industry 
(technology). As science should be in principle codified and public knowledge, a major motivation for 
clustering – i.e. local spillovers of tacit knowledge - would seem to be absent. 
 Moreover, biotechnology is characterised by a very particular form of industry structure, with a 
pronounced division of innovative labour between universities and other research organisations, 
specialised biotechnology firms and large corporations and the development of dense networks of 
relationships among these agents.  
 Thus, important questions arise concerning:  
- how much are innovative activities actually spatially concentrated?  
- what are the specific reasons for clusterisation? 
- Are the agglomeration processes similar across different geographical areas? 
 
 
3.1 Evidence of agglomeration 
There is indeed strong evidence that innovative activities in biotechnology tend to cluster in 
specific geographical areas. 
First of all, innovative activities are strongly concentrated in few countries and particularly in 
North America. In terms of patents the US are and continue to be the most important locus of 
innovation in biotechnology, with a share of around 50% (both as USPTO and EPO patents are 
concerned)  followed by Japan, Germany, UK, and France, Canada and Australia. Spatial concentration 
has been increasing over time. From 1990 to 2000, the United States increased by 9 percentage points 
its share of all biotechnology patents granted by the USPTO. The share of Japan declined by 11 %. A 
modest ncrease occurred in the case of Denmark (+ 1.1%), while Germany lost a little ground (- 1.2%). 
The shares of all other European countries have remained relatively stable over the last decade.  In 
Asia, new clusters are emerging in Singapore and Taiwan.The spatial concentration of innovative 
activities is even stronger in terms of patent citations. The share of citations to US patents is 
substantially higher (around 55%) than the share of simple counts and reaches around 65% for “highly 
cited” patents (i.e. patents receiving at least 10 citations in the period not counting self-citations) in the 
period 1978 – 1995 (with citations up to 1997) (Allandottir et al., 2001). 
Second, innovative activities are strongly concentrated  in specific regions within national 
States, in terms of patents and even more so in terms of number of firms, research institutions and 
employment. In the US, biotechnology has been characterised, historically, by a relatively high 
concentration of firms and employment in a restricted number of regions. In particular, the Bay Area 
and  Boston established themselves as the main locations of the emergent biotechnology industry. Later 
on, as the industry developed, other regions have become important clusters: San Diego, New Jersey, 
New York metropolitan area, Maryland (between Baltimore and Washington DC), and Texas (Dallas 
and the Houston area in Texas) (see Owen Smith, Riccaboni, Pammolli, Powell, 2002; Zucker, Darby,  
et al. 1998). 
In Canada,  biotechnology activities are concentrated around a few large and medium-sized 
urban agglomerations, like Toronto, Montreal, Vancouver, Ottawa, Edmonton and Calgary, while more 
specialised clusters have also emerged around smaller cities (Niosi and Bas 2001) 
 Similarly, in Europe a relatively small number of local clusters are capturing a dominant 
majority of biotechnology firms and of public research organisations. Some of these clusters (i.e. 
Oxford, Cambridge, and Stockholm) are more consolidated and can rely upon sound research 
background and high international reputation, coupled with a critical mass of both young and 
established spin-off companies and international contacts. Other biotechnology clusters, like the 
German Bio-Regions (Munich, Rhine/Neckar and Rhineland), some French districts and, to a lesser 
extent, the Medicon Valley between Copenhagen and Lund, are younger, having taken off during the 
Nineties (Allansdottir et al, 2001).  
 In the UK, British DBFs are clustered in East Anglia (Cambridge), South East England 
(Oxfordshire, Great London, Surrey), and Central Scotland.  A circle of 10 kilometres includes most of 
the activities around the Oxford and Cambridge Campuses, as well as within the City of London. 
In Germany, German DBFs tend to be localised in Bayern, Baden-Württenberg, Rheinland-
Pfalz, Nordrhein-Westfalen, and Berlin.  In France, biotechnology firms are mainly concentrated in 
Paris, the second largest cluster in terms of number of DBFs in Europe after Cambridge. According to 
BID data, about 30% of French biotechnology firms are located in Paris trailed by a group of French 
regions (Auvergne, Loire, Rhone-Alpes and Midi Pyrennees) that have been catching up in the last five 
years (Allansdottir et al, 2001)  
In Sweden , almost all biotechnology firms are located in four major regions: Stockholm-
Uppsala, Skåne, which is the southern region including Lund and Malmö, Gothenburg and Umeå while 
in Denmark they are highly concentrated in the Sjælland Island. The southern region, (Øresund) is 
known as Medicon Valley (Horton, 1999). Medicon Valley has grown up between Copenhagen and 
Lund–Malmö, especially after the construction of the bridge between Denmark and Sweden.  Other fast 
growing clusters are in Finland (Helsinki, Turku, Tampere, Kuopio, Oulu), in the Netherlands (Zuid-
Holland Region), and in Lombardia (Milan) (Allansdottir et al, 2001). 
 In sum, the evidence in favour of clustering would seem to be overwhelming. Moreover, it is 
hard to find relevant examples of commercial biotechnology activities that do not occur in clusters. 
However, a few questions and caveats are in order here. 
First, what are the properties of the dynamics of spatial concentration of biotechnology 
innovative activities over time? Is this concentration increasing or decreasing over time? Do the early 
clusters continue to dominate the industry or are they replaced by new clusters? 
Second, is spatial concentration in biotechnology innovative activities stronger or weaker as 
compared to other technologies or industries? 
In both cases, there is little systematic evidence available. Casual empiricism seems to suggest 
that as innovative activities increase over time, new clusters are formed but they do not tend to replace 
the early leaders (See for instance Powell et al., (2002); Prevezer (2003)). On the contrary, they 
continue to maintain – and perhaps increase – their leadership. The overall effect on concentration is 
therefore ambiguous. Similarly, there is little evidence of phenomena of decline of clusters. If anything, 
new clusters may face difficulties in their growth but no significant shake-out appears to characterise 
industry evolution in its spatial dimension.  
As it concerns the second question, there is even less direct evidence. Clearly, direct 
comparisons are inherently difficult given heterogeneity in data, measures, age and degree of 
development, etc.., but on the whole little is known about differences in spatial concentration in 
innovative activities across industries and technologies. In this respect it might be worthwhile 
mentioning the results obtained by Mariani (2001), according to whom biotechnology appears to be 
caracterised by lower degrees of spatial concentration – measured in terms of co-location of inventors 
as they appear in patent documents – as compared to other chemical – related patents. 
 These finding suggest a further interesting point. Innovative activities in biotechnology would 
seem to show lower degrees of concentration in terms of  innovation – as measured by patents – as 
compared to other related technologies and above all than in terms of number of firms. Paradoxically, 
this observation would seem to reverse the now conventional stylised fact that innovation is more 
concentrated than production. Of course, this depends – in the case of biotech – on the role played as 
inventors by those research institutions and especially large firms which are located outside the cluster 
and on the very particular nature of industry structure in biotechnology. Thus, the criteria and the 
measures by which clusters are defined are likely to influence significantly the conclusions.  
 
 
 
3.2 The ingredients of clusters 
Almost all of the studies on biotechnology concentrate their attention on a set of ingredients that 
are usually thought to be important constituents of clusters: 
a)    the scientific base 
b) entrepreneurship, venture capital and a favourable IPR regime 
c) linkages with large firms and other industries 
d) institutions, policies and other infrastructures  that support and promote 
entrepreneurship. 
 
3.2.1 The scientific base 
There is little question that all biotechnology clusters are found in locations where there exists a 
strong concentration of scientific capabilities and institutions. Both case studies and econometric 
evidence (e.g. Prevezer (1997), (2001), (2203); Swann and Prevezer (1996); Swann, Prevezer and Stout 
(1998); Zucker, Darby and Brewer (1998); Audretsch and Stephan (1996)) strongly support this view. 
 However, beyond this observation, several further questions remain open. In particular, it is 
less clear what kind of institutions are important; what kind of sientific research is really important; and 
what exactly is the shape of the relation between  the strength of the knowledge base and the (various 
measures of ) performance of the cluster. 
A strong academic base seems to be a recurrent ingredient. However, other types of research 
institutions are often mentioned to play a significant role: national laboratories, hospitals and medical 
schools, laboratories of large corporations. Indeed, one observes a significant variation in this respect. 
In the case of the US, for example, the leading clusters (the Bay Area and Boston) are not typically 
home of the labs of the large corporations. Viceversa, San Diego hosts mainly public and private 
research laboratories, but academic research is not as prominent as in the two previously mentioned 
clusters. The Capitol region is a different case again, characterised by the presence of the NIH and 
other public institutions (e.g. Walter Reed Army Institute for Research and the FDA), but less advanced 
university-based research (Feldman, 2001). In the case of Canada, Niosi and Bas (2003) report that 
government laboratories do not emerge as important factors in explaining clustering: if anything, their  
research capabilities – as measured by by patents) appears to be negatively correlated with with 
variables like the number of patents held by DBFs,  number of DBFs, number of patenting DBFs.  
As far as Europe – especially Continental Europe - is concerned, the situation is similar, 
although the role of research organisations different from universities appears to be relatively more 
prominent. Indeed,  most of the leading European clusters include a variegated set of public and private 
research organisations. This might reflect, especially in Continental Europe, different patterns of 
organisation of research: in countries like Germany and France, for example, public laboratories like 
the Max Planck Gesellschaft or the Institute Pasteur rather than universities have been traditionally the 
main performers of basic research. 
Rather than the specific nature of the relevant research organisations, what might turn out to be 
more important is the absolute level of excellency in research, the degree of variety in research and the 
interactions among organisations. Thus, Zucker and Darby (1995; Zucker et al.,1998) show that 
academic research as such explains little of  new firms formation and their performance, but it is rather 
the presence of star scientists that leads to start-ups and agglomeration. Audretsch and Stephan (1996) 
confirm this finding, by showing that geographic proximity does not play an important role for for links 
between biotechnology companies and scientists in general, but it becomes crucial when linkages 
between scientists who are founders of a start-up  - as distinct from scientists serving as members of the 
Scientific Advisory Board are considered.   
Second, variety and diversification of scientific research within the cluster appears to play a 
significant role. Owen-Smith et al (2001), by analysing the co-location of innovative activities on the 
grounds of two different patent, data sets and two research collaboration data sets, show that American 
clusters are characterised by a larger number of different typologies of research organisations, 
operating in a wide spectrum of  scientific areas and with substantial integration along the various 
stages of the processes of drug discovery and development. In contrast, laggard European clusters 
appear to be much more specialised and less integrated, both along the horizontal and the vertical 
dimension.  
Similarly, Audretsch and Feldman (1999) stress that diversity of the science base at a location 
supports innovative activities to a greater extent than specialisation: the presence of of diverse 
industries within the same science base in a city leads to increased innovation. Along the same lines, 
Prevezer (2003) and Swann and Prevezer (1996) show that the links between science base and 
companies are supplemented by links between a number of industrial sectors. Primarily, therapeutics 
exerts a strong pull for the entry of new firms in diagnostics, agricultural and equipment , while activity 
in one’s own sector serves a mild deterrent to entry. In general, firms with complementary, rather than 
similar specialisations are attracted to each other and tend to enter a cluster together. Partially different 
results are obtained however by Aharonson, Baum and Feldman (2004), who provide evidence that  
firms located in clusters that were strong in their technological specialization applied for patents at 
more than twice the rate of firms located in clusters that were strong in another specialization.  
Moreover, they show that new entrants in a cluster tend to locate near incumbent firms that engage in 
innovative activities close to the entrants’ own technological specialization when those firms spend 
more on R&D, but also that  stronger innovative activity of firms in other specializations results in a 
denser co-location to firms in the same specializations: as another specialization becomes more 
important in the cluster, entrepreneurs appear to seek out firms that are similar to themselves. 
 
3.2.2  Entrepreneurship and incentives for the exploitation of academic research 
Finally, as it is clear that a strong scientific base is a fundamental ingredient of clustering, it is 
also clear that it is not a sufficient condition. Examples abound of cases of areas where a strong 
scientific base has failed to spawn dynamic clusters (see Audretsch (2001); Orsenigo (2001)). Other 
factors, linked to the willingness and ability to exploit such knowledge for economic purposes, have 
been consistently identified as crucial ingredients of the clustering process. 
As a general proposition, this assumption is dangerously close to a truism: if a cluster is defined 
in terms of agglomeration of economic activities, then it obvious that economic considerations are 
crucial for the explanation.  The proposition becomes much more interesting and controversial as soon 
as the specific factors leading to and/or allowing for the decision to commercially exploit knowledge 
are examined. 
Entrepreneurship is again quite obviously a fundamental characteristic. Yet, as such the notion 
of entrepreneurship explains little in the case of biotechnology. In many instances, the propensity to 
entrepreneurship is considered as a psychological and/or a social characteristic.  Especially in this 
second interpretation, the explanation of  differentials in entrepreneurial attitudes across space plays a 
significant role in the debate. Clusters are indeed often defined and explained as geographical areas 
where entrepreneurial attitudes are particularly developed, for various historical reasons, and are 
continuously reproduced by the cluster itself (see Becattini (1990) and Saxenian (1994) among others). 
Without denying the crucial relevance of these factors, a discussion of the notion of entrepreneurship 
falls quite obiously beyond the scope of this paper. It might be just worthwhile mentioning – with 
specific reference to the case of biotechnology – that attitudes towards entrepreneurship cannot account 
as such for the underdevelopment of biotechnology in Italy, a country which exhibits very high rates of 
new formation but in sectors quite different form biotechnology.  
In a more subtle interpretation, entrepreneurship is not considered simply as a psychological 
and social attitude, but as a specific form of organisation of innovative activities, typically contrasted 
with the traditional picture of vertically and horizontally  integrated large corporations (e.g. Saxenian 
(1994)). This is indeed an important argument and it plays undoubtedly a crucial role in the case of 
biotechnology, especially as it concerns the differences between the performance of the USA vs. 
Europe. In any case, it is perhaps more fruitful to concentrate attention first on the factors that might 
facilitate or hinder entrepreneurship and the development of decentralised, network-like forms of 
organisation of innovative activities, assuming for the sake of discussion – that individual and social 
propensities are evenly distributed across space.  
Rules governing academic involvement in commercial activities, IPRs and venture capital are in 
fact commonly referred to as essential factors that might account for the differential performance of the 
USA as compared to Europe and Japan. 
In fact, the development of the biotechnology industry in the USA rested on the concomitant 
growth of series of supporting organizations and institutions which are now perceived as defining the 
distinct character of the “American way” to innovation, at least in high-tech industries and especially in 
biotechnology. This system is typically described as being based on three interconnected pillars: 
university-industry interactions, a strong intellectual property rights regime (which favours the 
commercialisation of scientific research) and venture capital. 
The key role of scientific knowledge for technological innovation in biotechnology (and in 
other industries) has indeed manifested itself in an unprecedented intensification of both industry-
university ties and in the direct involvement of academic institutions and scientists in commercial 
activities. Both phenomena are certainly not  new in the USA (Rosenberg and Nelson (1993),  Mowery 
et al (2001)). However, since the mid-Seventies and over the whole evolution of the biotechology 
industry,  the drive towards an increasing commercialization of the results of research accelerated 
dramatically. Universities’ patenting and licencing  activities started to soar. The creation of academic 
spin-offs has become a distinct and crucial phenomenon of the American academic system and of the 
biotechnology industry..   
The emergence of the entrepreneurial university and the specific forms this process took in the 
USA are strictly linked to some basic characteristics of the US academic system. American universities 
had been  traditionally highly responsive to the needs of the local communities and industries. Also the 
organization of research and teaching had characteristics that facilitated both the production of high 
quality research and high degrees of mobility between academia and the commercial world.  
 Specifically, as shown by sociologists of academia  (Ben-David (1977), Clark (1995)), in the 
USA (and in Great Britain) departments have long been the main organizational entities as opposed to 
the European institutes, dominated by a single professor, far less interdisciplinary in nature and with 
feudal-like career paths. Moreover, in the USA high degrees of integration between  teaching and 
learning have been achieved through the sharp separation between undergraduate and post-graduate 
levels.  The creation of research-oriented post-graduate studies entailed, in fact, a number of important 
consequences. In particular, post-graduate students are typically exposed and trained to the practice of 
scientific research within research teams composed by students and professors within departmental 
organizations. This arrangement does not only tend to free resources for scientific research, but 
provides also a fundamental experience in participating to and managing relatively complex 
organizations. In other words, it constitutes an essential source for the development of organizational 
capabilities. Moreover, the career of young research scientists after graduate studies has – under 
various perspectives -  entrepreneurial characteristics. For instance, post-docs have to raise funds for 
their own research in a highly competitive environment, where performance is judged on the basis of a 
track record and the ability to set an independent research agenda (Gittelman, 1999). Finally, graduate 
students joining the industrial world after the completion of their studies constitute an essential source 
of skilled demand for academic research.  
 In Continental Europe, the integration of teaching with research has progressed far less than in 
the USA (and to some extent than in the UK). Clearly, enormous differences in education systems, 
especially on the higher education level, exist across Continental European countries and they certainly 
should not be overlooked. For example, as it was mentioned previously, in France, universities have 
never been the main center of both scientific research - which has been essentially conducted within the 
national laboratories and co-ordinated by the CNRS (National Center for Scientific Research) - and the 
education of the elites - monopolized by the system of the grandes écoles. In Germany, the “institute” – 
dominated by an individual professor – has been the main organizational unit co-ordinating teaching 
and research.  
Despite these enormous differences, the structure of the academic systems of many European 
countries shares some important common features, as compared to the Anglo-Saxon systems. Ph.Ds are 
a relatively recent innovation in many Continental European countries and they remain far less 
professionally orientated than in the U.S.A. Departmental structures are also relatively new and in 
many cases institutes continue to be a very important organizational entity. In general, research has 
tended to be far more removed from teaching than in the USA. And in fact, in many Continental 
European countries, research has been to a large extent separated from universities and concentrated in 
specialized institutions  (Ben- David (1977), Clark (1995)). At the cost of oversimplification, in Europe 
a model has been emerging based on high degrees of division of labor and specialization between 
teaching and research institutions, whereas in the USA the dominant model has been an integrated one 
(Bruno and Orsenigo, (2003). 
 It is possible to speculate that this separation might have had negative effects on both the 
quality of research and on the ability of academic institutions to interact with industry. Integration of 
research and teaching and collaboration with industry has been relatively more developed and frequent 
in the case of engineering schools (the Continental European polytechnics) and in some selected 
disciplines in particular countries (chemistry in Germany). In the 1960-70s, however, with the 
development of mass academic education, the scientific revolutions linked mainly to microelectronics 
and molecular biology (developed mainly in the USA) and the crisis of the traditional industries mainly 
connected with the polytechnics, in many cases industry-university interaction has further weakened. 
To remedy this gap, a re-proposition of the “specialized model” has tended to spread in more recent 
years for the management of the interactions between research and industry and technology transfer. 
Differently from the US case, where universities have gradually extended their functions (an integrated 
model centered on universities), one observes in Continental Europe the development of various types 
of specialized institutions for technology transfer, who act as intermediaries between research and 
industry (an institutional specialization model).  
The coupling between scientific, organizational and entrepreneurial capabilities thus constitutes 
an essential pre-condition for subsequent developments in industry-university relations. However, it is 
also  important to notice that such developments are to some extent to be considered as part of a much 
more general tendency towards the diffusion of an increasingly favourable attitude towards the 
establishment and enforcement of  strong intellectual property rights. 
  The establishment of clearly defined property rights played indeed an important role in making 
possible the explosion of new firm foundings in the US, since the new firms, by definition, had few 
complementary assets that would have enabled them to appropriate returns from the new science in the 
absence of strong patent rights (Teece, 1986). In the early years of "biotechnology" considerable 
confusion surrounded the conditions under which patents could be obtained. In the first place, research 
in genetic engineering was on the borderline between basic and applied science. Much of it was 
conducted in universities or otherwise publicly funded, and the degree to which it was appropriate to 
patent the results of such research became almost immediately the subject of bitter debate. Similarly a 
growing tension emerged between publishing research results versus patenting them. Whilst the norms 
of the scientific community and the search for professional recognition had long stressed rapid 
publication, patent laws prohibited the granting of a patent to an already published discovery (Merton, 
1973; Kenney, 1986). In the second place the law surrounding the possibility of patenting life-formats 
and procedures relating to the modification of life-forms was not defined. This issue involved a variety 
of problems (see OTA, 1993), but it essentially boiled down first to the question of whether living 
things could be patented at all and second to the scope of the claims that could be granted to such a 
patent (Merges and Nelson, 1994; Mazzoleni and Nelson, 1995).   
In fact, these trends were partly spurred by a growing concern about how to exploit more 
efficiently academic research and by the need to put some order in the system that governed the 
conditions at which universities could obtain patents – and therefore income - on the results of publicly 
funded research. The Bayh-Dole Act in 1980 sanctioned these attitudes, by greatly facilitating 
university patenting and licensing.   Parallel to Bayh-Dole, a series of judicial and Congress decisions 
further strengthened the appropriability regime of the emerging sectoral system. In 1980, the US 
Supreme Court ruled in favor of granting patent protection to living things (Diamond v. Chakrabarty), 
and in the same year the second reformulation of the Cohen and Boyer patent for the rDNA process 
was approved. In the subsequent years, a number of patents were granted establishing the right for very 
broad claims (Merges and Nelson (1994). Finally, a one year grace period was introduced for filing a 
patent after the publication of the invention. 
The third pillar of this emerging system was of course venture capital. Once again, venture 
capital was a long-standing institution in the American financial and innovative system. It was already 
active – in various forms – ever since the 1920s (or even before) and emerged as a vibrant industry 
with the electronic revolution in the 1960s. Most likely, the existence of a vibrant venture capital 
industry which developed with the ICT revolution was a factor that favoured in different ways the 
emergence of the Bay Area and Boston as leading biotechnology clusters (Prevezer (2001), Audretsch 
(2001), Niosi and Bas (2003)).  
However, it has to be emphasised that these factors  - industry-university relations, IPRs and 
venture capital – were not simply pre-existing at the onset of the biotechnology industry, but they co-
evolved over time. 
First,  as Mowery et al (2001) have shown, the emergence of the “industry-university complex” 
(Kenney, 1986) and of the entrepreneurial university pre-dates Bayh-Dole.  Similarly, other studies 
(e.g. Kortum and Lerner (1998)) concur in indicating that the growth of patenting activities in the USA 
over the past 10-20 years does not seem to have been spurred so much by a tighter appropriability 
regime, but rather on the the rise of the two main technological revolutions of the second half of the 
century, micro-electronics and, especially biotechnology. Thus, the  relationship between patent 
protection, innovation and commercialisation of academic research appears to be much more complex 
than it would appear at first sight. New technological opportunities have provided new opportunities 
for invention and for its economic exploitation as well as improvements in the productivity of R&D. 
Stronger and wider IPRs have certainly incentivized and facilitated the commercialization of academic 
research, especially in the form of academic spinoffs, but the extent to which they have also directly 
spurred invention remains more doubtful. To the extent that the development of biotechnology rests 
primarily on the absolute excellence of scientific research, the influence of IPRs on innovative 
activities in biotechnology appears mediated by  this latter factor.  
Moreover, the IPR regime cannot account for geographical differentials in performance within 
countries, both as it concerns the USA and Europe,  being a nationwide, rather than a cluster-specific 
factor. Even in Europe, no simple and direct relationship can be found between the development of 
biotechnology – at the nation state level, let alone at the clusters level - and IPRs regimes. If anything, 
the explanation might might then turn on the observation of more aggressive attitudes and better 
organisational structures of specific universities towards IPRs and technology transfer in different 
clusters. The case-studies literature does indeed provide evidence of this (Audretsch (2001), Niosi and 
Bas (2003)). A somewhat different, but germane interpretation is provided by Feldman (2001) in her 
analysis of the case of the Capitol region, where entrepreneurship was unleashed by on the one hand 
exogenous events like the  downsizing in federal employment  and increasing reliance on outsourcing 
and – on the other hand – by a mix of government policies that created demand for ICT and 
biotechnology services, as incentives and pressures for the appropriation and commercialisation of 
public research, despite the feeble commitment of some important research institutions (e.g Johns 
Hopkins) towards academic entrepreneurship. 
Perhaps more interestingly, it is important to stress again that changes in IPRs regimes and 
greater “entrepreneurial” attitudes on the part of academics have themselves been spurred by the 
initiative of  individuals, firms, industry organisations etc., in knowledge-rich environments which 
offered the opportunities for innovation and new firms creation.  Similarly, while there is ample 
evidence that local availability of venture capital facilitates the development of new biotechnology 
firms, much less evidence is available that this was a necessary precondition for the take-off of the 
industry. In many cases, in Europe new firms have been founded resorting to capital located outside the 
cluster and even outside the the country and clusters have developed attracting venture capital rather 
than finding it already present within the location (Orsenigo 2001; Allansdottir at al. (2001)) 
 
3.2.3. Local demand, institutions, infrastuctures and policies 
Analogous remarks can be suggested as it concerns the other factors that are usually claimed to 
be important ingredients of a cluster. While there is little question that these factors are usually present 
in a successful cluster, there is much less evidence about their specific nature and that they are a 
necessary pre-condition for the development of a cluster. 
Thus, for example, Niosi and Bas (2001) find that biotechnology clusters in Canada are located 
in in large metropolitan areas, comprising high level research is conducted in prestigious institutions, 
an ample pool of venture capital, large and research –oriented hospitals, etc.. Aharonson, Baum and 
Feldman (2004) also support the finding that urbanisation economies are an important factor in the 
Canadian biotechnology industry. Similar results are found for some European clusters (e.g. the 
Stockholm area), although in general clusters appear to form around centres of academic excellence, 
rather than cities a such (Allansdottir et al 2001; Pammolli and Riccaboni, (2001)).   
Similarly, the local presence of large corporations does not systematically emerge as a 
fundamental ingredient of clusters. Large companies are frequently located outside the cluster, both in 
the USA and Europe, although linkages between local actors and big corporations is invariably a 
crucial component of the successful development of a biotechnology industry. Moreover, in some 
European cases, there are instances where new firms are created as spinoffs of large firms undergoing 
processes of restructuring, typically after episodes of M&As (Orsenigo (2001)). 
 As already mentioned, the existence of related industries and the relations between the various 
segments of the biotechnology industry appears in some studies as an important determinant of the 
(local) development of biotechnology (Prevezer (2003) and Swann and Prevezer (1996)). However, 
such relations are quite intricated and appear to vary significantly across different clusters and types of 
firms (Lemariè et al. (2001), Corolleur et al. (2003)).  
 Finally, the degree of variability is even higher in terms of policies. Reviewing the literature in 
this case is a tremendously difficult. Two main general (and generic) conclusions in this respect might 
simply be that: 
i) especially but not exlusively in the American cases, early successful clusters developed 
almost spontaneously without any direct intervention, although even in these instances, the 
initiative of particular (and diverse) institutions plays an important role in the cluster; 
ii) especially in Europe, one observes a bewildering variety of policies at the nation and 
regional level to foster the development of biotechnology. A fair assessment would seem to 
be that it is almost impossible to draw any kind of generalisation, both as it concerns 
experiences of success and failure. The development of successful clusters has been 
achieved through wildly different approaches: surely, there is no single way, let alone 
recipe, to success. On the other hand, failure is pervasive, irrespective of the policies that 
have been adopted. 
3.2.4. Some final remarks about ingredients 
This discussion suggest few conclusions and many open questions. 
The dominant and robust result is that excellency in scientific research spanning over a 
differentiated spectrum of areas and integration along the horizontal and vertical dimensions of the 
innovative process are the crucial ingredients for the development of biotechnology. The role of the 
other factors appears to be ancillary or irrelevant, absent these capabilities. 
Conversely, the developed, successful clusters appear to profit from the concomitant presence 
of all the ingredients, although their role and specific nature varies significantly.  Yet, in many cases, 
these ingredients were not simply in place simultaneously at the beginning, i.e. at the time of the 
genesis of the cluster. Certainly, those locations where most of these conditions are or were available 
enjoy(ed) significant advantages. But this neither a necessary nor a sufficient condition. Rather, in 
almost all cases, the process of construction of such ingredients would seem to be a crucial part of the 
story: in a sense the process is a fundamental ingredient itself. 
Putting it in other words, clusters are born and develop on the basis of specific combinations of 
capabilities, incentives and opportunities. The three elements are inseparable and linked to each other 
in intricated ways. Competencies obviously contribute to create and define opportunities as well as the 
ability to take advantage of existing opportunities. The latter feed back on the processes of 
accumulation and development of new competencies. Competencies without incentives remain unused. 
But incentives without sufficient capabilities are sterile and might even be destructive. More 
interestingly, particular sets of  capabilities identify sets of appropriate incentives, which in turn and 
once again influence the speed and directions of the processes of accumulation of competencies. 
Understanding how different types of opportunities, incentives and capabilities match with each other 
would require sophisticated taxonomical exercises and hard theorising. This appears to be a 
fundamental chapter in the agenda of future research. (see Hall and Soskice (2001), Casper and Kettler 
(2001) for an interesting and promising attempt in this direction). 
 
3.3 Processes: mechanisms of agglomeration, networks and network dynamics 
The evidence on ingredients tells a story whereby clusters are not simply born with all the 
necessary ingredients in place, but in many instances such ingredients  are rather constructed and 
developed over time. In other cases, the empirical evidence reviewed so far hints and sometimes openly  
recognizes (Feldman 2001) some “historical accident” unleashing self-reinforcing processes on the 
basis of  cutting edge scientific research and  variegated and wide-ranging scientific and technological 
capabilities. The preceding discussion highlights also that a dynamic perspective is useful and probably 
necessary to understand the forces leading to clusterisation. Thus, in this section,  attention is focused 
on the available evidence concerning how biotechnology clusters develop over time. 
In particular, linking also to the broader theory and empirical analysis of the spatial concentration 
of production and innovation, the question can be reframed around the following issues: 
 a) Can concentration of innovative activities be “predicted” on the basis of some “static” pre-
conditions (e.g. “endownments” and comparative advantages), much alike standard models of 
trade? 
b) Given particular sets of initial conditions, what are the main processes  leading to 
agglomeration?  
c) In particular, how much does clustering result from processes of  continuous reproduction of 
competencies (e.g.spin-offs from universities) and from processes of  attraction of competencies 
generated elsewhere? 
d) More specifically, what are, if any, the particular advantages of agglomeration itself?  
 
3.3.1 Static preconditions and mechanisms of agglomeration 
As now already mentioned in several occasions, the crucial role of strong scientific capabilities, 
particulary academic research, is the single better established “stylised fact” in the analysis of the 
evolution of the biotechnology industry.  Consistently, in all econometric analyses and case studies, 
variables measuring the strength of the knowledge base turn out as the “best predictor” of performance. 
From this point of view, clustering of innovative activities is certainly not a purely random 
phenomenon which could have happened (or might happen in the future) anywhere.  
 However, this predictor is not an exceedingly good one. Thus, it becomes particularly important 
to examine the nature of the processes underlying the development of  the biotechnology industry and 
its clusterisation. 
However, little systematic evidence exists on the relative importance of alternative mechanisms 
of agglomeration in biotechnology. The previous discussion on the “ingredients” seems to suggest that 
classical Marshallian externalities related to the availability of skilled labour and economies of intra-
industry specialisation (see in particular Prevezer (2003), Swann and Prevezer (1996), Aharonson, 
Baum and Feldman (2004)) play indeed an important role in generating agglomeration. However,  
almost all the case studies and the econometric findings by Aharonson, Baum and Feldman (2004)) 
emphasise consistently that proximity to universities and/or other sources of knowledge is important 
and the usual explanation is that it makes the circulation of tacit knowledge easier. Similar arguments 
are provided as it concerns venture capital: detailed knowledge of the opportunities offered by the 
knowledge-creating institutions, personal acquaintance with the scientists, continuous monitoring of 
companies are fundamental aspects of venture capital and this knowledge is much easier to be acquired 
at the local level. 
 However, the already mentioned evidence provided by Zucker at al (1995, 1997, 1998 and 
1998a) and by Audretsch and Stephan (1996) points to a radically different account. In essence, they 
suggest that the standard notion of geographically localised knowledge spillovers does not seem to 
apply to the case of biotechnology industry, at least in the phase of its emergence. Rather, they argue 
that discoveries in this technological area are characterised by high degrees of natural excludability, i. 
e. that the techniques for their replication are not widely known and anyone wishing to build on new 
knowledge must gain access to the research team or laboratory setting having that know-how. In these 
circumstances, the discovering scientists (‘superstars’) tend to enter into contractual arrangements with 
existing firms (contract or ownership) or start their own firm in order to extract the supra-normal 
returns from the fruits of their intellectual human capital. Moreover, the scientist work with or create a 
new firm within commuting distance of home or university (where they tend to retain affiliation) thus 
creating localised effects of university research.  
These authors show that the innovative performance of biotechnology firms is positively 
associated to the total number of articles by local university ‘star’ scientists. However, when the 
number of articles written by university stars is broken down into those written in collaboration with 
firm scientists (‘linked’) and the remaining (‘untied’), the coefficient on articles written by local 
university stars not in collaboration with the firm loses its significance and nearly vanishes in 
magnitude. Previous evidence on the existence of indiscriminate localised knowledge spillovers seems 
therefore to have resulted from a specification error, i. e. the inability to control for the actual 
relationships linking individual scientists to individual firms. 
Similarly, Audretsch and Stephan (1996) confirm that geographic proximity is important only 
or mainly for scientists who are founders of companies, whereas members of the Scientific Advisory 
Board are much less co-localised. Corelleur at al. (2003) also show in ther econometric analysis of the 
French case that geographical localisation effects impact significantly on the localisation of new firms, 
but as firms grow these effects become much less important, confirming the earlier results obtained by 
Prevezer (2003) and  Swann and Prevezer (1996). 
These results suggest interesting insights. 
First, the role of knowledge spillovers might have been overestimated in the case of 
biotechnology. On the contrary, knowledge tends to remain sticky within the cluster for rather different 
reasons linked to attempts at privately appropriating knowledge and restricting its circulation.  
Naturally excludable and rivalrous knowledge does not spill over, but people (teams) embodying 
knowledge move (locally) across organisations in order to exploit the value of their knowledge. In 
other terms, localised effects of university and industry research are most likely to result primarily from 
a combination of appropriability of tacit non-replicable knowledge and low geographical as well as 
organisational mobility of researchers (Breschi and Lissoni (2001).  
Second, the relevance of “soft” institutions might also have been overestimated. Knowledge 
flows in the biotechnology industry appear to be channelled  significantly through market transactions 
and inter-organisational rules. In this perspective, biotechnology would look much more similar to a 
market for technology (Arora et al., 2004) than to the classical notion of the industrial district.  In 
between these two extremes, knowledge flows appear to be structured in a fundamental way by the 
social and technical rules of interaction that govern scientific and technological research, as it will be 
discussed at some more length in the next paragraph. 
Third, this interpretation is consonant with – albeit not identical to -  the model proposed by 
Klepper (2002) for the automobile industry. According to this view, as discussed in Section 2, 
clustering results from processes of spin-off – as distinct from spillovers – from knowledge-rich 
organisations: companies in the case of automobiles, universities in the case of biotechnology.  These 
organisations perform as incubators of capabilities which are then exploited in the form of new firms 
and more generally of the formation of a pool of highly skilled labour force. Going back to the 
discussion in Section 2, it would appear that increasing returns, in addition to externalities, are 
fundamental movers of the processes of agglomeration. The study by Romanelli and Feldman (2004) in 
this volume constitutes in this perspective a first and important attempt to disentangle empirically the 
mechanisms through which this type of increasing returns work, at least in the case of biotechnology. 
In particular, they show that around 75% of the biotherapeutics firms founded in the USA over the 
period  1976-2002 identified in their analysis have a local origin, i.e. they spun off from institutions, 
especially universities, but also other companies, located in the same geographical area. Moreover, 
successful clusters continue to exhibit high rates of internal firms formation, whereas weaker clusters 
are characterized by both lower domestic prolificness and higher propensity to migrate. Attraction of 
entrepreneurship from outside the clusters appears also to be a significant phenomenon. In other words, 
two interlinked and self-reinforcing processes seem to drive the evolution of clusters. First, a process of 
spinoff from local  institutions and organizations – similar to Klepper's account – originates and 
sustains the cluster. Second, on these bases, immigration of new entrepreneurs and firms having an 
origin from outside the cluster is set in motion which strengthens and overlap with the former.   
Fourth, the relevance of the local knowledge base is likely to change over time, as clusters 
evolve and mature; and across different typologies of firms. Moreover, local knowledge has a different 
impact on the entry and on the growth of firms. As already mentioned, local sources of knowledge 
appear to be fundamental in the early stages of the devevlopment of a cluster and for new, higly 
specialized firms. Access and ability to use (and integrate) external “ knowledge becomes increasingly 
important for growth and diversification (Lemariè et al. (2001), Corelleur at al. (2003) Prevezer (2003) 
and  Swann and Prevezer (1996)). 
Fifth, these (partial and not entirely congruent) results might also begin to shed some light on 
the dynamic mechanisms that determine the advantages of agglomeration. Once again, rather than 
relying on spillovers as such, clusterization might be interpreted as the outcome of the intrinsic 
difficulties involved in the reproduction of knowledge outside their specific original contexts. Thus, 
spinoffs and startups tend to locate close to their “parents” and relatives also because what they know 
derives from region-specific practices, ways of doing things, etc.. , and their replication occcurs with 
higher probability and ease within the same context. Clealry, much more research is needed here (for 
example, looking at differential patterns of growth and peformances of local vs. immigrated firms).   
  
 
3.3.2 Externalities, increasing returns and networks 
 The literature on networks in biotechnology provides further insights into this discussion, 
particularly as it concerns the role of the local knowledge base, the mechanisms that regulate the flows 
of knowledge and their dynamics over time. 
 There is  no need to elaborate on the idea that networks of collaborative relationships among 
firms and other institutions are a fundamental form of  organization of innovative activities in 
biotechnology. In fact, one finds in the literature widely different interpretations of the nature, 
motivations, structure and functions of these networks, ranging from more sociologically oriented 
approaches to economic explanations based on (various mixes of) alternative theoretical backgrounds, 
e.g. transaction costs, contract theories, game theory and competence-based accounts of firms' 
organization.  
According to an influential interpretation, collaborations represent a new form of organization 
of innovative activities, which are emerging in response to the increasingly codified and abstract nature 
of the knowledge bases on which innovations draw (Arora, Gambardella, 1994; Gambardella, 1995). 
To be sure, substantial market failures exist in the exchange of a commodity like information. 
However, the abstract and codified nature of science, coupled with the establishment of property rights 
on such knowledge,  makes it possible, in principle, to separate the innovative process in different 
vertical stages.  Different types of institutions tend to specialize in the stage of the innovative process in 
which they are more efficient: universities in the first stage, small firms in the second, big established 
firms in the third. In this view, then, a network of ties between these actors can provide the necessary 
coordination of the innovative process in a division of innovative labor. Collaborations are likely to be 
a permanent feature of the industry, with a large (and possibly continuously expanding) number of 
entities interacting with each other, generating an intricate network within which each subject 
specializes in particular stages of the innovative process getting benefits from an increasing division of 
innovative labor.  
According to another interpretation, collaborative relations are instead considered as a transient 
phenomenon, bound to decrease in scale and scope as the technology matures and as higher degrees of 
vertical integration are established in the industry (Pisano, 1991). 
Finally, according to interpretations focusing on network advantages, the complex and 
interdisciplinary nature of relevant knowledge bases in pharmaceutical R&D tends to make 
technological innovations the outcome of interactions and cooperation among different types of agents 
commanding complementary resources and competencies (Sharp, 1985; Orsenigo, 1989; Pisano, 1991; 
Pammolli, 1997). In this perspective, it has also been suggested that the locus of innovation (and the 
proper unit of analysis) is no longer a firm, but the network itself (see Powell, Koput, Smith-Doerr, 
1996). In this case, the direction of causation is reversed: it is the structure of the network and the 
position of agents within it that fundamentally determine agents' access to relevant sources of scientific 
and technological knowledge and therefore innovative activities and performances (see also Walker et 
al., 1997). 
Without entering directly into this discussion, for the purposes of the present paper it suffices to 
highlight some broad results that have emerged from network-based studies which bear direct 
relevance to geographical clusters. 
The first basic result is that participation in networks is indeed fundamental to firms. In other 
words, innovative activities in biotechnology are strongly embedded in networks of relationships and 
the position within the network is a powerful explanatory variable of firms’ performance (Powell et al 
(1996); Barley, Freeman and Hybels (1992), Walker, Kogut and Shan (1997)). 
 Second, the performance of specific geographical networks is strongly associated to high 
degrees of internal differentiation in roles and behaviour, diversity of actors and linkages but also by 
the presence of actors who act as integrators of such diverse agents and relationships. Thus, Owen-
Smith et al. (2002) compare the structure of the American and European networks in biomedical 
research. They show that the US network is characterised by extensive relationships between U.S. 
public research organizations and firms located in dense regional clusters that span therapeutic areas, 
cross multiple stages of the development process, and involve diverse collaborators. In contrast, 
European innovative networks are characterized by sparser, more specialized and upstream 
relationships among a more limited set of organizational participants located in national clusters. Both 
U.S. and European networks are geographically clustered, then, but in quite different manners. 
Similarly, Pammolli and Riccaboni (2001) and Allansdottir et al (2001) conclude, in their analysis of 
the European biotechnology clusters, that  clustering derives to a large extent by the availability of a 
strong, heterogeneous but integrated research base that facilitates the transfer and the integration of 
knowledge, as well as the development of skilled labour, the mobility of such labour and – presumably 
– also the development of other supporting institutions like venture capital. 
However, networks have a strong geographical dimension and overlap but do not coincide with 
geographical clusters. Not only networks of relationships usually span well beyond the boundaries of 
the geographical location, but the performance of the individual nodes within the network and of 
specific geographical networks is strongly associated to high degrees of openness to geographical 
distant nodes (see Owen-Smith at al. (2001),  Pammolli and Riccaboni (2001), Allansdottir at al. 
(2001) among others). Moreover, in a dynamic perspective, the growth of  geographical networks and 
the tendency towards towards clustering is accompanied by a parallel process of increasing openness of 
the original clusters. In Europe, recent trends suggest a combination of an increasing number of 
collaborations and a decreasing proportion of local connections (Pammolli and Riccaboni (2001), 
Allansdottir at al (2001). In the USA too, local ties moved from a high of 40% in 1988 to a low of 8% 
in 1998 (Owen-Smith, Riccaboni, Pammolli, Powell, 2001), in the context of a rising volume of 
collaborations (the number of ties active in 1998 is more than double the number a decade before). In 
general, the recent evolution of the biotechnology industry appears to have resulted from a combination 
of an increasing number of collaborations and a decreasing proportion of local connections, confirming 
other findings provided by  econometric analyses and case studies, which consistently show that better 
performing and growing firms rely increasingly less on local sources of knowledge (Corolleur et al., 
2003).  
Third, network studies vividly show that the  flows of knowledge occurring in a network  are 
structured and mediated by a host of different mechanisms, among which geographical proximity is 
only one and it neither  necessarily  important. Thus, for instance, the rules presiding over the 
participation to scientific communities and communities of practice (Breschi and Lissoni 2003) or 
organisational proximity (Rallet and Torre (1998)  define the principles of inclusion and exclusion as 
well as  the channels through which knowledge is transmitted within the network. In many instances, 
such diverse rules and principles interact with each other, giving rise to novel patterns of interaction 
(see Murray, (2004) for an analysis of  the differentiated rules governing the interactions between 
scientists, technologists and entrepreneurs in science-based start-ups). Other studies show that the 
access to the network of collaborations in biotechnology is not unrestricted. On the contrary, the 
network of collaborative relationships itself tends to consolidate and to become increasingly 
hierarchical, while also exhibiting expansion. Despite this growth, however, the network tends to 
consolidate around a rather stable core of companies, composed by large incumbents and early entrants 
in the network. This suggests the existence of first-mover advantages even in the network of 
collaborations, whose core becomes increasingly difficult to enter as time goes by  and can be 
perturbed only and temporarily by new major technological discontinuities (see Orsenigo, Pammolli, 
Riccaboni, 2001).What is important to emphasise here is not only that these patterns of interaction are 
distinct from geographical proximity but also that what might appear as knowledge spillovers are 
actually the outcome of extremely complex structures. In other words, knowledge is not simply in the 
air, but can be accessed and transmitted only by compliance with a variety of interacting rules, which 
only in some cases happen to have a geographical dimension.  If anything, the question might then be 
turned over: why and under what circumstances do those rules acquire a geographical embeddedness? 
Fourth, once again network studies show that networks, patterns of agglomeration and more 
importantly the mechanisms determining the structure of the networks and of geographical clusters are 
different and change over time. For example, the above mentioned tendency towards the delocalisation 
of relationships in the European and American networks might derive from different factors. One most 
likely resides in the need to get access to state-of-the art knowledge, wherever it might be located. 
Sustained performances are based on leading edge research, which cannot be exclusively local. Second, 
the tendency towards clustering and subsequent delocalisation might also derive from the very 
properties of the evolution of knowledge in biotechnology.  As discussed in Pammolli (1997) and in 
Orsenigo, Pammolli, Riccaboni (2001), scientific progress in biotechnology led to an explosion of the 
search space, with a continuous proliferation and branching of hypotheses and techniques at increasing 
levels of specificity. No single institution is able to develop internally in the short run all the necessary 
ingredients for bringing new products on the marketplace. These properties of the knowledge base and 
of the related learning processes induced particular patterns of division of labour between different 
types of firms and institutions. In general, two different logics of exploration and technological advance 
co-existed and were strongly complementary in the evolution of the network. The first trajectory 
generated patterns of division of labour in which older generations of firms worked at higher levels of 
generality and linked with successive generations of new entrants, who typically embodied increasingly 
specific hypotheses and techniques. The second trajectory, linked esentially to the development of 
platform technologies, induced instead collaboration between all types of firms, modifying the inter-
generational structure of the agreements typical of the first trajectory.  
In a different, but complementary perspective, Powell et al (2005) show that four alternative 
logics of attachment -  accumulative advantage, homophily, follow-the-trend, and multiconnectivity - 
account for both the structure and dynamics of interorganizational collaboration in the field of 
biotechnology.  Commercialization strategies pursued by early corporate entrants are supplanted by 
collaborative activities influenced more by universities, research institutes, venture capital, and small 
firms.  As organizations increase both the number of activities on which they collaborate and the 
diversity of organizations with whom they are linked, cohesive sub-networks form that are 
characterized by multiple, independent pathways.  These structural components, in turn, condition the 
choices and opportunities available to members of a field, thereby reinforcing an attachment logic 
based on connections to diverse partners that are differently linked.   
 
4. Conclusion 
 This brief review of the literature on biotechnology clusters suggests – as mentioned in the 
intorduction – more questions than firm conclusions. 
The evidence strongly supports the view that there are indeed advantages to agglomeration and 
powerful forces leading to the development of clusters in biotechnology. Yet, the strength of these 
clustering tendencies differ according to the indicators that are used and there are suggestions that 
biotechnology might actually be less localised than other industries and technologies.  Moreover, what 
exactly those advantages and processes might be remains much less clear. They  appear to be mainly 
related mainly to the stock of accumulated scientific and R&D capabilities within a geographical area, 
e.g. to the presence of a variety of world class research institutions, which provide competencies and 
opportunities for innovation. Adequate incentives for the use of such knowledge for commercial 
purposes are also obviously important, although their nature and their effects may differ substantially 
across space and time. 
Thus, in the case of biotechnology, the emergence of clusters is certainly not a random 
phenomenon: initial conditions and “endownments” play certainly a crucial role in defining the 
geography of innovation in this field. However, these initial conditions are hardly interpretable as 
“given endownments” and do not suffice to account either for the genesis of clusters or for the failure 
of developing one.  
Moreover, it is hard and probably misleading to distinguish between the ingredients and the 
processes that underlie cluster formation and development.  
First, the processes do depend on and are shaped by initial conditions. Thus, different 
agglomeration forces may play a role under alternative initial circumstances. Indeed, the empirical 
evidence does not provide clear and homogeneous indications in this respect.  If anything, the evidence 
seems to support a picture whereby the spatial concentration of innovative activities derives mainly 
from processes of spin-off from highly capable universities and research centres. However, classical 
Marshallian externalities and urbanisation economies play  a significant role, but coupled with (and 
perhaps triggered by)  processes driven by the increasing returns intrinsic in the generation of 
knowledge. In any case, both case studies and econometric evidence tell different stories, from which is 
hard to draw strong generalisations. Similarly, little evidence is available on the relative role of the 
processes of firms formation originating within the cluster and processes of attraction of entrepreneurs 
initially located outside the cluster. 
In the same vein, the evidence concerning localised knowledge spillovers is mixed. On the one 
hand, a considerable body of results – both econometric studies and network studies – strongly suggest 
that knowledge is not simply in the air within a cluster, but knowledge flows are heavily structured by a 
variety of economic and social factors which in many instances do not have any clear geographical 
connotation. Yet, on the other hand, there are also overwhelming suggestions that indeed knowledge is 
spatially sticky and intense knowledge flows are an intrinsical characterstic of clusters. Most of this 
evidence is provided by case studies. Thus, the question might be asked if such knowledge flows are 
and can be captured by quantitative, econometric studies. But rather than simply dismiss the qualitative 
evidence, more efforts should be devoted to devise better measures and indicators. 
 Second, the evidence forcefully points to the observation that – as much as agglomeration 
forces are influenced by “structural” initial conditions – processes are the essence of what clusters are 
made of. The factors that lead to the genesis of a cluster are different from those that later sustain the 
cluster itself. The factors that influence firms’ entry in a cluster are at least partly different than those 
which promote firms’ growth. Again, it is hard to identify invariant processes across clusters. Yet, most 
of the case studies and of the dynamic network studies (but also some econometric results) suggest that 
clustering is the outcome of processes of construction and co-evolution of the conditions that allow 
clusters to exist, rather than the automatic effect of specific pre-conditions and agglomeration factors. 
In this sense, innovation generates clusters at least as clusters create innovation. 
As disappointing as these thin results might be, they at least clearly indicate that an explicit 
dynamic approach is necessary for further progress in this field, both in terms of empirical research and 
formal modelling. 
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